Comparison of treatment before versus after the introduction of NSF for coronary heart disease
| Before NSF (31 March 2000 or earlier; n = 1993) | After NSF (after 31 March 2000; n = 1378) | p Value | |
|---|---|---|---|
| Not all variables have complete data. | |||
| Number of eligible patients thrombolysed | 506/738 (69.4%) | 359/428 (84.7%) | <0.0001 |
| Number of eligible patients thrombolysed within 20 minutes | 55/506 (12.1%) | 91/359 (26.6%) | <0.0001 |
| Aspirin | 1787 (94.8%) | 1204 (90.9%) | <0.0001 |
| β Blockers | 968 (51.9%) | 870 (65.8%) | <0.0001 |
| Statins | 1024 (55.2%) | 956 (72.7%) | <0.0001 |
| ACE inhibitor | 690 (37%) | 879 (66.4%) | <0.0001 |
| Referral for in-hospital coronary angiography | 357 (18.3%) | 366 (27.0%) | <0.0001 |